Concepedia

M McLaughlin

MM

Statistics

Publications

4

Citations

420

H-Index

4

Active since

2016

Affiliations

University College London(Current)

M McLaughlin is an author at University College London specializing in diabetes, metabolic syndrome, and medicine.

Top concepts

Publications per year

2016–2024

4

Publications

4

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 337 citations · Full text

, , +7

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 34 citations · Full text

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 31 citations · Full text

Osteopathic Manipulative Treatment for Older Patients: A National Survey of Osteopathic Physicians

Millicent King Channell, Yvette Wang, M McLaughlin et al. · Journal of Osteopathic Medicine · 2016 · 18 citations · Full text

1–4 of 4